Last checked at 15 Jan 2013 12:15
ECO Animal Health Group plc (ECO)
(AIM:EAH)
Issue of Equity and Director Dealing
The Company announces that certain employees and directors have exercised an aggregate of 59,640 options in the Company.
The details of the options exercised by the directors are as follows:
| Director name | No. of options | Exercise price | |||||||
| Marc Loomes | 8,000 | £1.085 | |||||||
| Brett Clemo | 16,000 | £1.085 | |||||||
| Julia Trouse | 7,640 | £1.085 | |||||||
The 59,640 ordinary shares have been sold by the relevant employees and directors and been purchased by Peter Lawrence at an average price of 240 pence per ordinary share.
Accordingly the directors' shareholdings remain unchanged following this transaction except for Peter Lawrence who has an interest in 11,268,176 ordinary shares representing 20.36% of the Company's issued share capital.
Application has been made for the admittance to trading of 59,640 ordinary shares in the Company as a result of this exercise of options. It is anticipated that these shares will be admitted to trading on 18 January 2013.
Following the admittance to trading of the 59,640 ordinary shares, total number of ordinary shares in issue will be 55,337,516 .
Contacts:
| ECO Animal Health Group plc | |||||||||||||
| Peter Lawrence | 020 8336 6190 | ||||||||||||
| Spiro Financial | |||||||||||||
| Anthony Spiro | 020 8336 6196 | ||||||||||||
| Cenkos Securities plc (Nominated Adviser) | |||||||||||||
| Stephen Keys | 020 7397 8926 | ||||||||||||
ECO Animal Health Group plc is a leader in the development, registration and marketing of pharmaceutical products for animals. Our products for these global growth markets promote well-being. Our financial goals are achieved through the careful and responsible application of science to generate value for our shareholders.
Copyright Business Wire 2013